✦ LIBER ✦

Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

✍ Scribed by Fernando O. Recio; M.Steven Piver; Ronald E. Hempling; Deborah L. Driscoll

Book ID: 112247318
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 104 KB
Volume: 68
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1998.4940

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of survival after second-line

Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer

✍ M. Steven Piver; Fernando O. Recio; Trudy R. Baker; Deborah Driscoll 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Second line platinum-based intraperitone

Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer

✍ TOMASZ MILCZEK; DAGMARA KLASA-MAZURKIEWICZ; JANUSZ EMERICH; JULIUSZ KOBIERSKI 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 68 KB

Five-year survival for cisplatin-based c

Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery

✍ M. Steven Piver; James Fanning; Henry E. Sprance 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

The purpose of this study was to evaluate 5-year survival and 5-year progression-free survival in previously untreated patients with advanced ovarian cancer treated with single-agent melphalan in which very few patients underwent optimal debulking surgery (<2 cm residual) as compared with the patien

Peritoneal fibrosis leading to small bow

Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer

✍ Warren S. W. CHAN; Robert BOHMER; Robert MCINTOSH; Penelope BLOMFIELD 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 105 KB

Second-line chemotherapy with irinotecan

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

✍ Daisuke Takahari; Yasuhiro Shimada; Shigeyuki Takeshita; Hitoshi Nishitani; Atsu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 156 KB

Intraperitoneal cisplatin versus no furt

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

✍ M. J. Piccart; A. Floquet; G. Scarfone; P. H. B. Willemse; J. Emerich; I. Vergot 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB